The LTCBTC ratio has hit a support line on which it has always bounced higher since the end of April 2017 (if the flash crash by the end of May is taken out of consideration). EDIT on 20 Aug 2017: The lower spike from 25 May is specific to the COINBASE exchange but is not present […]
EUR/CHF – The Swiss Franc Lowers its Guard against the Euro Trooper
Let’s address the $EUR/CHF pair from a dynamic technical analysis viewpoint with a multiple time frame approach. It may look a bit complex and somewhat too technical for the layman but with some explanations it will become very clear. The graph presented is on a closing basis from Thursday, August 17 2017; by the time […]
Aurinia Pharmaceuticals – Healthy correction to buy
Aurinia Pharmaceutical ( NASDAQ: $AUPH ) is an absolutely perfect Weinstein play: breakout of resistance line with an explosion of trading volumes, a rising 30-week average, strongly positive relative strength. The stock price follows perfectly the script and offers a new buying opportunity by hitting back the previous resistance line now turned into support line […]
EURTRY – Something must yield!
In a previous post I mentioned the extremely overbought condition of the $USDTRY pair. The situation is not any different regarding the $EURTRY pair. Therefore it appears that the turkish Lira should be close to ending its multi-year decline since August 2012 (bottom left of the chart) and is on the verge or recovering some […]
BYD – An electric trap
The case for BYD (OTC PINK: $BYDDY) – the leading Chinese electric vehicles and renewable energy company – is very clear. The share price is entrapped in a long term contracting triangle and it has been painfully climbing a wall of worries since it bottomed in mid-2011. The 30-week moving average is trending upwards but […]
Myokardia Inc. – That stock is going to the moon, or at least I think
Myokardia Inc. ( NASDAQ: $MYOK) made an impressive weekly close with an anthology of Weinstein Stage II breakout criterias: – Breakout from Stage I – No overhead resistance – Rising 30-week moving average – Extremely positive Relative Strength – Massive volume increase It certainly has the potential of being a super-winner and to rise… “to […]
Editas Medicine – Accumulation phase
Editas Medicine ( Nasdaq: $EDIT ) is a gene editing company at the leading edge of the revolutionary CRISPR technology. The rising exchange volumes on the weekly scale has the hallmarks of rising interest and shares accumulation, whereas the relative strength is also progressively rising and should soon turn positive. Last week the price broke […]
Lithium X Energy Corp. – Watch breakout above 2.25 CAD
Lithium X Energy Corp. (TSX-V: #LIX / OTCQB: #LIXXF) – a lithium exploration and development company – appears technically well positioned to benefit from the coming electric mobility boom. On a monthly chart the stock market price is consolidating within a long term contracting triangle that follows an initial parabolic rise from a low at 0.35 […]
Turkish Lira – massively oversold against the US Dollar
The $USDTRY pair appears to be extremely overbought on longer time frames, which in other terms means that the Turkish Lira is massively oversold against the Greenback. On the six-month time frame this overbought condition is accompanied by a shooting star candle, which is a strong indication that the uptrend should stall (for the least) […]
NNO break-out
To follow-up on the analysis posted two days ago, Nano One Materials Corp. #NNO (TSX-V) broke out during yesterday’s session (chart below does not account for the intraday high at 1.28 CAD).
Nano One Materials Corp. set to double
Nano One Materials Corp. #NNO (TSX-V) is “a Canadian technology company with a scalable industrial process for producing low cost high performance battery materials and a wide range of other advanced nanostructured composites”, in particular with battery materials such as Lithium and Cobalt. The stock appears to have built a long term bottoming base and […]
MAZOR Robotics (MZOR), a perfect long term biotech play
#Mazor Robotics (MZOR) appears to be a perfect Weinstein winner. The price broke out of its long term trading range in March 2017 with a strong volume increase and with a positive relative strength compared to the NASDAQ Composite Index. The current consolidation phase should soon give way to higher prices. Disclosure: I am long […]